Literature DB >> 3182084

Plasmodium chabaudi malaria: protective immunization with surface membranes of infected erythrocytes.

F Wunderlich1, H H Brenner, M Helwig.   

Abstract

Plasmodium chabaudi-susceptible NMRI and B10.A mice were vaccinated with host cell plasma membranes isolated from P. chabaudi-infected erythrocytes. Most of the mice were protected from the lethal consequences of challenge with the homologous parasite, although protection was unassociated with a reduction in the course or peak of parasitemia. Vaccination also induced the production of antibodies against Pc90, which is the immunodominant protein expressed by parasites in host cell plasma membranes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182084      PMCID: PMC259746          DOI: 10.1128/iai.56.12.3326-3328.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Membrane structure and function of malaria parasites and the infected erythrocyte.

Authors:  I W Sherman
Journal:  Parasitology       Date:  1985-12       Impact factor: 3.234

4.  Induction of crisis forms in cultured Plasmodium falciparum with human immune serum from Sudan.

Authors:  J B Jensen; M T Boland; M Akood
Journal:  Science       Date:  1982-06-11       Impact factor: 47.728

5.  Development of Plasmodium chabaudi in mouse red blood cells: structural properties of the host and parasite membranes.

Authors:  F Wunderlich; H Stübig; E Königk
Journal:  J Protozool       Date:  1982-02

6.  Cryptic disposition of antigenic parasite proteins in plasma membranes of erythrocytes infected with Plasmodium chabaudi.

Authors:  F Wunderlich; M Helwig; G Schillinger; V Speth
Journal:  Mol Biochem Parasitol       Date:  1988-07       Impact factor: 1.759

7.  Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.

Authors:  S L Hoffman; C N Oster; C V Plowe; G R Woollett; J C Beier; J D Chulay; R A Wirtz; M R Hollingdale; M Mugambi
Journal:  Science       Date:  1987-08-07       Impact factor: 47.728

8.  Association between human serum-induced crisis forms in cultured Plasmodium falciparum and clinical immunity to malaria in Sudan.

Authors:  J B Jensen; M T Boland; J S Allan; J M Carlin; J A Vande Waa; A A Divo; M A Akood
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  Isolation and characterization of parasites and host cell ghosts from erythrocytes infected with Plasmodium chabaudi.

Authors:  F Wunderlich; M Helwig; G Schillinger; H Vial; J Philippot; V Speth
Journal:  Mol Biochem Parasitol       Date:  1987-03       Impact factor: 1.759

  9 in total
  19 in total

1.  Protective vaccination alters gene expression of the liver of Balb/c mice in response to early prepatent blood-stage malaria of Plasmodium chabaudi.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Abdel Azeem S Abdel-Baki; Denis Delic; Frank Wunderlich
Journal:  Parasitol Res       Date:  2018-02-05       Impact factor: 2.289

2.  Protective vaccination and blood-stage malaria modify DNA methylation of gene promoters in the liver of Balb/c mice.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Abdel-Azeem S Abdel-Baki; Foued Ghanjati; Lars Erichsen; Simeon Santourlidis; Frank Wunderlich; Marcos J Araúzo-Bravo
Journal:  Parasitol Res       Date:  2017-03-18       Impact factor: 2.289

3.  Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites.

Authors:  Qifang Shi; Amy Cernetich; Thomas M Daly; Gina Galvan; Akhil B Vaidya; Lawrence W Bergman; James M Burns
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Cloning and sequencing of a cDNA fragment from Plasmodium chabaudi chabaudi that contains repetitive sequences coding for a potentially lysine-rich aspartic acid-rich protein.

Authors:  D Hartz; M Ayane; J Chluba-De Tapia; C Wirbelauer; J Langhorne; S Gillard-Blass
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

5.  A cDNA putatively encoding the Pc90 erythrocyte membrane antigen of Plasmodium chabaudi.

Authors:  H P Schmitt-Wrede; Z D Qiao; F Wunderlich
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

6.  Hepatic miRNA expression reprogrammed by Plasmodium chabaudi malaria.

Authors:  Denis Delić; Mohamed Dkhil; Saleh Al-Quraishy; Frank Wunderlich
Journal:  Parasitol Res       Date:  2010-11-18       Impact factor: 2.289

7.  Blood-stage malaria of Plasmodium chabaudi induces differential Tlr expression in the liver of susceptible and vaccination-protected Balb/c mice.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Suliman Alomar; Abdel Azeem S Abdel-Baki; Denis Delic; Frank Wunderlich; Marcos J Araúzo-Bravo
Journal:  Parasitol Res       Date:  2016-01-25       Impact factor: 2.289

Review 8.  Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function.

Authors:  Owain R Millington; Caterina Di Lorenzo; R Stephen Phillips; Paul Garside; James M Brewer
Journal:  J Biol       Date:  2006-04-12

9.  Remarkable stability in patterns of blood-stage gene expression during episodes of non-lethal Plasmodium yoelii malaria.

Authors:  Amy Cernetich-Ott; Thomas M Daly; Akhil B Vaidya; Lawrence W Bergman; James M Burns
Journal:  Malar J       Date:  2012-08-06       Impact factor: 2.979

10.  Augmented particle trapping and attenuated inflammation in the liver by protective vaccination against Plasmodium chabaudi malaria.

Authors:  Jürgen Krücken; Denis Delić; Heike Pauen; Anna Wojtalla; Manal El-Khadragy; Mohamed A Dkhil; Horst Mossmann; Frank Wunderlich
Journal:  Malar J       Date:  2009-04-02       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.